In vivo and in vitro allergy diagnostics: it's time to reappraise the costs

Abstract

Recombinant allergens for specific IgE in vitro measurement provide more reliable information for immunotherapy prescription. This should be translated into a significant reduction in the overall costs sustained by the healthcare system.